不久前,全国人大副委员长韩启德在接受媒体专访时明确表示:卫生部决定取消医院药品加价,以改变长期形成的“以药养医”机制。与此相呼应的另一则消息是,发改委价格司近日召集全国各地物价部门医药价格处负责人进行了降价方案最后一轮定稿的讨论。一份基本成熟的方案已经上报至国务院等待批复,据说有望于近期公布。尽管有关方面强调取消医院药品加成及药品价格调整方案还在讨论之中,目前还没有出台的具体时间表。但来自高层的态度鲜明的表态,使业内各方纷纷判读一场事关医药行业的降价风暴行将来临。不论最终结果如何,委员长访谈如平地惊雷,已引发业内普遍关注和讨论。围绕这一最新焦点话题,本刊假座北京三博脑科医院举行主题座谈会,邀请医院院长、卫生经济管理专家、行业咨询机构负责人、药品供应商等多位资深业内人士对这一新政的政策背景和未来走势倡言立意。 Not long ago, Han Qide, vice chairman of the National People’s Congress, made it clear in an interview with the media: The Ministry of Health decided to cancel the hospital drug fare increase in order to change the long-established mechanism of “relying on medicine and medicine”. Another echoes of this news is that the Price Department of the NDRC convened a discussion on the final round of price reduction plan conducted by the head of the price department of medicine in price departments throughout the country recently. A basically mature plan has been submitted to the State Council awaiting approval, is said to be expected to be announced soon. Although the parties concerned stressed the cancellation of hospital drug additions and drug price adjustment programs are still under discussion, there is no specific timetable for promulgation. However, the stance from top-level stance clearly made all parties in the industry read a stalemate that the price-cutting storm in the pharmaceutical industry is approaching. Regardless of the final result, interviews with chairmen and grandmaters have aroused widespread concern and discussion in the industry. Around this latest focus of the issue, the publication of the Beijing Sabo Brain Hospital held a themed symposium, invited hospital dean, health economic management experts, industry advisory body responsible for drug suppliers and many other veterans of this new Deal The policy background and future trends advocate intention.